不良信息中英文对照
ICH-GCP中英文对照(完整)
ICH-GCP中英文对照(完整)ICH 三方协调指导原则 E6 ICH GCP指导原则INTRODUCTION前言Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible.临床试验管理规范（GCP）是设计、实施、记录和报告设计人类对象参加的试验国际性伦理和科学质量标准。
遵循这一标准为保护对象的权利、安全性和健康，为与源于赫尔辛基宣言的原则保持一致以及临床试验数据的可信性提供了公众保证。
The objective of this ICH GCP Guideline is to provide a unified standard for the European Union (EU), Japan and the United States to facilitate the mutual acceptance of clinical data by theregulatory authorities in these jurisdictions. ICH-GCP指导原则的目的是为欧盟、日本和美国提供统一的标准，以促进这些管理当局在其权限内相互接受临床数据。
IQC 常用英文介绍
名字在母片中修改
Page 10
back adhesive deformation Unit hardness Material Brass Tin-lead Nickel Color
背膠 變形度 單位 硬度 材料,材質 黃銅 錫鉛 鎳 顏色
torque Burr Plating Stainless Steel Solder Alloy
Page 9
检验常见英文词汇
Capacitance 電容值 Resistance 電阻值 Inductance 電感 Impedance 阻抗 Damage 損壞 Rust 生鏽 Unclear Printing 印刷不清 Polarity 兩極 inch 英寸 centimeter 厘米(cm) millimeter 毫米(mm) 1 inch= 2.539998 centimeter=25.3998 millimeter Scratch 刮傷 Dent 凹痕 Diameter 直徑 Width 寬度 Length 長度 Spot 斑點 Electro Static Discharge 靜電釋放 Golden sample 确认样品 Limited sample 限度样品
Prepared by
厂别
名字在母片中修改
Page 8
检验常见英文词汇
Appearance 外觀 Dimension 尺寸 Vendor 供應商 Tolerance 公差 Information 信息 Visual 目視 Calipers 卡尺 Marking 標識/記號 P/N part number 料號 Version 版本 Description 描述 Manufacturer 製造商 Technical Parameter 技術參數 Measure 測量 Date Code 日期代碼 Packaging 包裝 Body Color 本體顏色 Solderable 焊接性 Solder 錫膏 Revision 修訂 Oxidize 生鏽 Data Comparison 信息/數據比對 Input Voltage 輸入電壓 Output Voltage 輸出電壓 Assembly 組裝 Criteria 標準 Fixture 固定裝置/治具 Defect symptom 不良症狀(現象)
CRA专业术语中英文对照
缩略语英文全称中文全称ADE Adverse Drug Event 药物不良事件ADR Adverse Drug Reaction 药物不良反应AE Adverse Event 不良事件AI Assistant Investigator 助理研究者BMI Body Mass Index 体质指数CI Co-investigator合作研究者COI Coordinating Investigator 协调研究者CRA Clinical Research Associate 临床监查员（临床监察员）CRC Clinical Research Coordinator 临床研究协调者CRF Case Report Form 病历报告表CRO Contract Research Organization 合同研究组织CSA Clinical Study Application 临床研究申请CSA Clinical Study Agreement 临床研究协议CTA Clinical Trial Application 临床试验申请CTX Clinical Trial Exemption 临床试验免责CTP Clinical Trial Protocol 临床试验方案CTR Clinical Trial Report 临床试验报告DSMB Data Safety and monitoring Board 数据安全及监控委员会EDC Electronic Data Capture 电子数据采集系统EDP Electronic Data Processing 电子数据处理系统FA Financial Agreement 财务协议FDA Food and Drug Administration美国食品与药品管理局FR Final Report 总结报告GCP Good Clinical Practice 药物临床试验质量管理规范GLP Good Laboratory Practice 药物非临床试验质量管理规范GMP Good Manufacturing Practice 药品生产质量管理规范IB Investigator’s Brochure 研究者手册IC Informed Consent 知情同意ICF Informed Consent Form知情同意书ICH International Conference on Harmonization 国际协调会议IDM Independent Data Monitoring 独立数据监察IDMC Independent Data Monitoring Committee 独立数据监察委员会IEC Independent Ethics Committee 独立伦理委员会IND Investigational New Drug 新药临床研究IRB Institutional Review Board 机构审查委员会IVD In Vitro Diagnostic 体外诊断IVRS Interactive Voice Response System 互动语音应答系统MA Marketing Approval/Authorization 上市许可证MCA Medicines Control Agency 英国药品监督局MHW Ministry of Health and Welfare 日本卫生福利部NDA New Drug Application 新药申请NEC New Drug Entity 新化学实体NIH National Institutes of Health 国家卫生研究所（美国）PI Principal Investigator 主要研究者PL Product License 产品许可证PMA Pre-market Approval (Application) 上市前许可（申请）PSI Statisticians in the Pharmaceutical Industry 制药业统计学家协会QA Quality Assurance 质量保证QC Quality Control 质量控制RA Regulatory Authorities 监督管理部门SA Site Assessment 现场评估SAE Serious Adverse Event严重不良事件SAP Statistical Analysis Plan 统计分析计划SAR Serious Adverse Reaction 严重不良反应SD Source Data/Document 原始数据/文件SD Subject Diary 受试者日记SFDA State Food and Drug Administration国家食品药品监督管理局SDV Source Data Verification 原始数据核准SEL Subject Enrollment Log 受试者入选表SI Sub-investigator 助理研究者SI Sponsor-Investigator 申办研究者SIC Subject Identification Code 受试者识别代码SOP Standard Operating Procedure标准操作规程SPL Study Personnel List 研究人员名单SSL Subject Screening Log 受试者筛选表T&R Test and Reference Product 受试和参比试剂UAE Unexpected Adverse Event 预料外不良事件WHO World Health Organization 世界卫生组织WHO-ICDRA WHO International Conference of Drug Regulatory Authorities WHO国际药品管理当局会议Active Control 阳性对照、活性对照Audit稽查Audit Report 稽查报告Auditor 稽查员Blank Control 空白对照Blinding/masking 盲法/设盲Case History 病历Clinical study 临床研究Clinical Trial 临床试验Clinical Trial Report 临床试验报告Compliance 依从性Coordinating Committee 协调委员会Cross-over Study 交叉研究Double Blinding双盲Endpoint Criteria/measurement 终点指标Essential Documentation 必需文件Exclusion Criteria 排除标准Inclusion Criteria 入选表准Information Gathering 信息收集Initial Meeting 启动会议Inspection 检察/视察Institution Inspection 机构检察Investigational Product 试验药物Investigator 研究者Monitor 监查员（监察员）Monitoring 监查（监察）Monitoring Plan 监查计划（监察计划）Monitoring Report 监查报告（监察报告）Multi-center Trial 多中心试验Non-clinical Study 非临床研究Original Medical Record 原始医疗记录Outcome Assessment 结果评价Patient File 病人档案Patient History 病历Placebo 安慰剂Placebo Control 安慰剂对照Preclinical Study 临床前研究Protocol 试验方案Protocol Amendments 修正案Randomization 随机Reference Product 参比制剂Sample Size 样本量、样本大小Seriousness 严重性Severity 严重程度Single Blinding 单盲Sponsor申办者Study Audit 研究稽查Subject 受试者Subject Enrollment 受试者入选Subject Enrollment Log 受试者入选表Subject Identification Code List 受试者识别代码表Subject Recruitment 受试者招募Study Site 研究中心Subject Screening Log 受试者筛选表System Audit 系统稽查Test Product 受试制剂Trial Initial Meeting 试验启动会议Trial Master File 试验总档案Trial Objective 试验目的Triple Blinding 三盲Wash-out 洗脱Wash-out Period 洗脱期。
ICH-GCP中英文对照(完整)
ICH 三方协调指导原则E6 ICH GCP指导原则INTRODUCTION前言Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with the principles that have their origin in the Declaration of Helsinki, and that the clinical trial data are credible.临床试验管理规范(GCP)是设计、实施、记录和报告设计人类对象参加的试验国际性伦理和科学质量标准。
遵循这一标准为保护对象的权利、安全性和健康,为与源于赫尔辛基宣言的原则保持一致以及临床试验数据的可信性提供了公众保证。
The objective of this ICH GCP Guideline is to provide a unified standard for the European Union (EU), Japan and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.ICH-GCP指导原则的目的是为欧盟、日本和美国提供统一的标准,以促进这些管理当局在其权限内相互接受临床数据。
信用卡常用词汇中英文对照说明
AA（Approval Code）核准密码（AA为电报简码）,消费款项（超过商户最低免授权交易金额者经授权后给予的核准密码）。
每笔需授权的消费都有授权密码，包含人工、CED、POS。
Account use （手工授权，包括MO/TO/网上授权）ACD（Automatic Call Distribution）,程控交换机自动分配拨入（Call-in）的电话并提交管理层统计资料的电脑系统。
ACD in + Available,计算客服人员 productivity的统计量, 即接听客户电话和等候客户电话的时间比例．Acquiring Bank 收单银行,办理签定特约商户以接受信用卡客户消费的银行．AFF(Air Frequent Flyer),飞行里程奖励办法. 持卡人使用信用卡购买机票, 可按里程折合点数, 到达一定点数时, 可以换乘头等舱或享受免费机票优惠. Affinity Card(认同卡),其他商业机构借助银行的发卡系统或资源, 发行类似信用卡的认同卡, 以达到宣传或服务自身会员目的。
一般而言，认同卡为发卡行与非营利机构发行的信用卡。
Annual Fee 年费,信用卡每年所缴的年费, 在会计处理上按12个月分摊记帐. ANR(Average Net Receivables) 平均余额,发卡单位平均应收客户款. Application 申请书,客户申请信用卡时填写的表格, 包含个人资料, 财务状况等。
A/R（Accounts Recievables）应收帐款, 三个月未收回者，应转入PDO(Post Due Obligation)。
Arbitration 仲裁,对于争议帐款，当收单行与发卡行在扣款流程进行完毕后仍争执不下时，交VISA或MCI的仲裁法庭裁决。
Attrition 剪卡,取消卡片。
Authorization 授权,持卡人在商户消费时，需经授权系统或授权人员取得交易核准码，这一过程称为授权。
警报中英文对照
1.重新调整参数 2.检查电子尺 3.重新更新系统 4.更换电子感应开关
9.Mould safety time 模具保护时间未响应
1.锁模位置设置不好 2.系统出错 3.机器故障 4.电子尺故障
1.重新调整参数 2.检查调整参数 3.锁模系统不正常 4.检查电子尺
10.No holding pressure (stroke time pressure) 无保压压力（行程时间压力） 11.Nozzle guard not closed 喷嘴安全坏 2.计时器开关坏记电器 3.传感器坏 4.无输出信号
1.更换开关 2.检查线路各输出点
20.Rotation transducer defective 转速传感器失效
1.机器无动作 2.I/O板成线路故障
1.无信号输出 2.检查线路
21.Safety door end svitch problem 2S,2-S2 安全门开关2-S1，2-S2故障
1.安全门未关好 2.行程开关坏 3.线路断路
1.重新关好门 2.更换开关 3.排查线路
22.Sscrew back not reached 螺杆退回不到位
1.料筒无料 2.位置设定不合理 3.背压过大
1.料斗加料 2.调整位置 3.减少背压
23.2SH9 defective 2SH9失效 24.3-B1 not active or defective 3-B1 未触发或失效
1.重新调整参数 2.更换电子尺 3.维修机器
5.Hydr mould safety problem 模保故障
1.位置设置不正确 2.模具有异物
1.重新调整速度压力位置 2.检查模具是否正常
6.Motor overload 马达过载
CRA专业术语中英文对照
缩略语英文全称中文全称ADE Adverse Drug Event 药物不良事件ADR Adverse Drug Reaction 药物不良反应AE Adverse Event 不良事件AI Assistant Investigator 助理研究者BMI Body Mass Index 体质指数CI Co-investigator合作研究者COI Coordinating Investigator 协调研究者CRA Clinical Research Associate 临床监查员（临床监察员）CRC Clinical Research Coordinator 临床研究协调者CRF Case Report Form 病历报告表CRO Contract Research Organization 合同研究组织CSA Clinical Study Application 临床研究申请CSA Clinical Study Agreement 临床研究协议CTA Clinical Trial Application 临床试验申请CTX Clinical Trial Exemption 临床试验免责CTP Clinical Trial Protocol 临床试验方案CTR Clinical Trial Report 临床试验报告DSMB Data Safety and monitoring Board 数据安全及监控委员会EDC Electronic Data Capture 电子数据采集系统EDP Electronic Data Processing 电子数据处理系统FA Financial Agreement 财务协议FDA Food and Drug Administration美国食品与药品管理局FR Final Report 总结报告GCP Good Clinical Practice 药物临床试验质量管理规范GLP Good Laboratory Practice 药物非临床试验质量管理规范GMP Good Manufacturing Practice 药品生产质量管理规范IB Investigator’s Brochure 研究者手册IC Informed Consent 知情同意ICF Informed Consent Form知情同意书ICH International Conference on Harmonization 国际协调会议IDM Independent Data Monitoring 独立数据监察IDMC Independent Data Monitoring Committee 独立数据监察委员会IEC Independent Ethics Committee 独立伦理委员会IND Investigational New Drug 新药临床研究IRB Institutional Review Board 机构审查委员会IVD In Vitro Diagnostic 体外诊断IVRS Interactive Voice Response System 互动语音应答系统MA Marketing Approval/Authorization 上市许可证MCA Medicines Control Agency 英国药品监督局MHW Ministry of Health and Welfare 日本卫生福利部NDA New Drug Application 新药申请NEC New Drug Entity 新化学实体NIH National Institutes of Health 国家卫生研究所（美国）PI Principal Investigator 主要研究者PL Product License 产品许可证PMA Pre-market Approval (Application) 上市前许可（申请）PSI Statisticians in the Pharmaceutical Industry 制药业统计学家协会QA Quality Assurance 质量保证QC Quality Control 质量控制RA Regulatory Authorities 监督管理部门SA Site Assessment 现场评估SAE Serious Adverse Event严重不良事件SAP Statistical Analysis Plan 统计分析计划SAR Serious Adverse Reaction 严重不良反应SD Source Data/Document 原始数据/文件SD Subject Diary 受试者日记SFDA State Food and Drug Administration国家食品药品监督管理局SDV Source Data Verification 原始数据核准SEL Subject Enrollment Log 受试者入选表SI Sub-investigator 助理研究者SI Sponsor-Investigator 申办研究者SIC Subject Identification Code 受试者识别代码SOP Standard Operating Procedure标准操作规程SPL Study Personnel List 研究人员名单SSL Subject Screening Log 受试者筛选表T&R Test and Reference Product 受试和参比试剂UAE Unexpected Adverse Event 预料外不良事件WHO World Health Organization 世界卫生组织WHO-ICDRA WHO International Conference of Drug Regulatory Authorities WHO国际药品管理当局会议Active Control 阳性对照、活性对照Audit稽查Audit Report 稽查报告Auditor 稽查员Blank Control 空白对照Blinding/masking 盲法/设盲Case History 病历Clinical study 临床研究Clinical Trial 临床试验Clinical Trial Report 临床试验报告Compliance 依从性Coordinating Committee 协调委员会Cross-over Study 交叉研究Double Blinding双盲Endpoint Criteria/measurement 终点指标Essential Documentation 必需文件Exclusion Criteria 排除标准Inclusion Criteria 入选表准Information Gathering 信息收集Initial Meeting 启动会议Inspection 检察/视察Institution Inspection 机构检察Investigational Product 试验药物Investigator 研究者Monitor 监查员（监察员）Monitoring 监查（监察）Monitoring Plan 监查计划（监察计划）Monitoring Report 监查报告（监察报告）Multi-center Trial 多中心试验Non-clinical Study 非临床研究Original Medical Record 原始医疗记录Outcome Assessment 结果评价Patient File 病人档案Patient History 病历Placebo 安慰剂Placebo Control 安慰剂对照Preclinical Study 临床前研究Protocol 试验方案Protocol Amendments 修正案Randomization 随机Reference Product 参比制剂Sample Size 样本量、样本大小Seriousness 严重性Severity 严重程度Single Blinding 单盲Sponsor申办者Study Audit 研究稽查Subject 受试者Subject Enrollment 受试者入选Subject Enrollment Log 受试者入选表Subject Identification Code List 受试者识别代码表Subject Recruitment 受试者招募Study Site 研究中心Subject Screening Log 受试者筛选表System Audit 系统稽查Test Product 受试制剂Trial Initial Meeting 试验启动会议Trial Master File 试验总档案Trial Objective 试验目的Triple Blinding 三盲Wash-out 洗脱Wash-out Period 洗脱期ical Research Associatejing, Shanghai, Guangzhou, Wuhan, Chengdu, Shengshanges:otocol compliance, ICH-GCP and other regulatory obligations at trial sites by standardized ctivitiesccuracy and authenticity of clinical data, manage investigational products and other trial lies, maintain adequate clinical trial documentation etcctivities in line with milestones (i.e. start-up, monitoring, closeout, etc.) in compliance with Ps and ICH-GCPd communication between sponsor and investigator, report related issues to the line mediatelye timely reporting of study information, which includes safety reporting to relevant study er and regulatory authoritiesrelated to clinical trial monitorings:elor or above in medical or above, majoring in medicine or pharmacy or relatedcient in office software, e.g word, excel, PPT etc.d communications and coordination skillsd written and oral Englishrience in CRO is preferredHome | About H&J | News | Services | Regulations | Our clients | CRA | China CRO。
临床试验常用中英文词汇
SFDA Glossary：GCP，GLP，TRIAL Accuracy 准确度Active control，AC 阳性对照，活性对照Adverse drug reaction，ADR 药物不良反应Adverse event，AE 不良事件Adverse medical events 不良医学事件Adverse reaction 药物不良反应Alb 白蛋白ALD（Approximate Lethal Dose）近似致死剂量ALP 碱性磷酸酶Alpha spending function 消耗函数ALT 丙氨酸氨基转换酶Analysis sets 统计分析的数据集Approval 批准Assistant investigator 助理研究者AST 天门冬酸氨基转换酶ATR 衰减全反射法AUCss 稳态血药浓度－时间曲线下面积Audit 稽查Audit or inspection 稽查／视察Audit report 稽查报告Auditor 稽查员Bias 偏性，偏倚Bioequivalence 生物等效应Blank control 空白对照Blind codes 编制盲底Blind review 盲态审核Blind review 盲态检查Blinding method 盲法Blinding/ masking 盲法，设盲Block 分段Block 层Block size 每段的长度BUN 尿素氮Carryover effect 延滞效应Case history 病历Case report form 病例报告表Case report form/ case record form，CRF 病例报告表，病例记录表Categorical variable 分类变量Cav 平均浓度CD 圆二色谱CL 清除率Clinical equivalence 临床等效应Crossover design 交叉设计Cross-over study 交叉研究Css 稳浓度Cure 痊愈Data management 数据管理Database 建立数据库Descriptive statistical analysis 描述性统计分析DF 波动系统Dichotomies 二分类Diviation 偏差Documentation 记录／文件Dose-reaction relation 剂量－反应关系Double blinding 双盲Double dummy 双模拟Double dummy technique 双盲双模拟技术Double-blinding 双盲Drop out 脱落DSC 差示扫描热量计Effectiveness 疗效Electronic data capture，EDC 电子数据采集系统Electronic data processing，EDP 电子数据处理系统Emergency envelope 应急信件End point 终点Endpoint criteria/ measurement 终点指标Equivalence 等效性Essential documentation 必须文件Ethics committee 伦理委员会Excellent 显效Exclusion criteria 排除标准Factorial design 析因设计Failure 无效，失败Final point 终点Fixed-dose procedure 固定剂量法Forced titration 强制滴定Full analysis set 全分析集GC－FTIR 气相色谱－傅利叶红外联用GC－MS 气相色谱－质谱联用Generic drug 通用名药Global assessment variable 全局评价变量GLU 血糖Good clinical practice，GCP 药物临床试验质量管理规范Good manufacture practice，GMP 药品生产质量管理规范Good non-clinical laboratory practice，GLP 药物非临床研究质量管理规范Group sequential design 成组序贯设计Health economic evaluation，HEV 健康经济学评价Hypothesis test 假设检验Hypothesis testing 假设检验International Conference of Harmonization，ICH 人用药品注册技术要求国际技术协调会，国际协调会议Improvement 好转Inclusion criteria 入选标准Independent ethics committee，IEC 独立伦理委员会Information consent form，ICF 知情同意书Information gathering 信息收集Informed consent，IC 知情同意Initial meeting 启动会议Inspection 视察／检查Institution inspection 机构检查Institution review board，IBR 机构审查委员会Intention to treat 意向治疗（——临床领域）Intention-to –treat，ITT 意向性分析（－统计学）Interactive voice response system，IVRS 互动式语音应答系统Interim analysis 期中分析Investigator 研究者Investigator's brochure，IB 研究者手册IR 红外吸收光谱Ka 吸收速率常Last observation carry forward，LOCF 最接近一次观察的结转LC－MS 液相色谱－质谱联用LD50 板数致死剂量Logic check 逻辑检查LOQ （Limit of Quantitation）定量限LOCF，Last observation carry forward 最近一次观察的结转Lost of follow up 失访Marketing approval/ authorization 上市许可证Matched pair 匹配配对Missing value 缺失值Mixed effect model 混合效应模式Monitor 监查员Monitoring 监查Monitoring report 监查报告MRT 平均滞留时间MS 质谱MS－MS 质谱－质谱联用MTD（Maximum Tolerated Dose）最大耐受剂量Multicenter trial 多中心试验Multi-center trial 多中心试验New chemical entity，NCE 新化学实体New drug application，NDA 新药申请NMR 核磁共振谱Non-clinical study 非临床研究Non-inferiority 非劣效性Non-parametric statistics 非参数统计方法Obedience 依从性ODR 旋光光谱Open-blinding 非盲Open-label 非盲Optional titration 随意滴定Original medical record 原始医疗记录Outcome 结果Outcome assessment 结果指标评价Outcome measurement 结果指标Outlier 离群值Parallel group design 平行组设计Parameter estimation 参数估计Parametric statistics 参数统计方法Patient file 病人档案Patient history 病历Per protocol，PP 符合方案集Placebo 安慰剂Placebo control 安慰剂对照Polytomies 多分类Power 检验效能Precision 精密度Preclinical study 临床前研究Primary endpoint 主要终点Primary variable 主要变量Principal investigator 主要研究者Principle investigator，PI 主要研究者Product license，PL 产品许可证Protocol 试验方案Protocol 试验方案Protocol amendment 方案补正Quality assurance unit，QAU 质量保证部门Quality assurance，QA 质量保证Quality control，QC 质量控制Query list，query form 应用疑问表Randomization 随机化Randomization 随机Range check 范围检查Rating scale 量表Regulatory authorities，RA 监督管理部门Replication 可重复RSD 日内和日间相对标准差Run in 准备期Safety evaluation 安全性评价Safety set 安全性评价的数据集Sample size 样本含量Sample size 样本量，样本大小Scale of ordered categorical ratings 有序分类指标Secondary variable 次要变量Sequence 试验次序Serious adverse event，SAE 严重不良事件Serious adverse reaction，SAR 严重不良反应Seriousness 严重性Severity 严重程度Significant level 检验水准Simple randomization 简单随机Single blinding 单盲Single-blinding 单盲Site audit 试验机构稽查SOP 试验室的标准操作规程Source data verification，SDV 原始数据核准Source data，SD 原始数据Source document，SD 原始文件Specificity 特异性Sponsor 申办者Sponsor-investigator 申办研究者Standard curve 标准曲线Standard operating procedure，SOP 标准操作规程Statistic 统计量Statistical analysis plan 统计分析计划Statistical analysis plan 统计参数计划书Statistical analysis plan，SAP 统计分析计划Statistical model 统计模型Statistical tables 统计分析表Stratified 分层Study audit 研究稽查Subgroup 亚组Sub-investigator 助理研究者Subject 受试者Subject diary 受试者日记Subject enrollment 受试者入选Subject enrollment log 受试者入选表Subject identification code，SIC 受试者识别代码Subject recruitment 受试者招募Subject screening log 受试者筛选表Superiority 检验Survival analysis 生存分析SXRD 单晶X－射线衍射System audit 系统稽查T1/2 消除半衰期Target variable 目标变量T－BIL 总胆红素T－CHO 总胆固醇TG 热重分析TLC、HPLC 制备色谱Tmax 峰时间TP 总蛋白Transformation 变量变换Treatment group 试验组Trial error 试验误差Trial master file 试验总档案Trial objective 试验目的Trial site 试验场所Triple blinding 三盲Two one-side test 双单侧检验Unblinding 揭盲Unblinding 破盲Unexpected adverse event，UAE 预料外不良事件UV－VIS 紫外－可见吸收光谱Variability 变异Variable 变量Visual analogy scale 直观类比打分法Visual check 人工检查Vulnerable subject 弱势受试者Wash-out 清洗期Washout period 洗脱期Well-being 福利，健康。